Frontiers in Pharmacology, 2017 · DOI: 10.3389/fphar.2017.00245 · Published: May 10, 2017
Spinal cord injury (SCI) is a devastating condition leading to permanent paralysis. Current drug treatments are limited because they often don't reach the injury site effectively or for long enough. This review explores using biomaterials to deliver drugs directly to the injured spinal cord. These materials, like hydrogels and fibers, can release drugs in a controlled manner over time. By carefully choosing biomaterials and drug release strategies, we can better target the complex physiological changes that occur after SCI, potentially leading to improved regeneration and recovery.
Biomaterials can deliver drugs directly to the site of spinal cord injury, reducing side effects associated with systemic administration.
Biomaterials can be engineered to release drugs over extended periods, matching the timeline of SCI pathophysiology.
Biomaterials can provide physical support and guidance cues to promote axonal regeneration and functional recovery after SCI.